Clinical Trials
8
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials
Baloxavir Versus Oseltamivir for Nursing Home Influenza Outbreaks
- Conditions
- Influenza, HumanInfluenzaInfluenza -Like Illness
- Interventions
- First Posted Date
- 2021-08-19
- Last Posted Date
- 2023-03-15
- Lead Sponsor
- Insight Therapeutics, LLC
- Target Recruit Count
- 1000
- Registration Number
- NCT05012189
- Locations
- 🇺🇸
Insight Therapeutics, LLC, Norfolk, Virginia, United States
Recombinant Influenza Vaccination in U.S. Nursing Homes
- Conditions
- Influenza, HumanInfluenza -Like IllnessInfluenza
- First Posted Date
- 2019-05-28
- Last Posted Date
- 2023-03-15
- Lead Sponsor
- Insight Therapeutics, LLC
- Target Recruit Count
- 1989
- Registration Number
- NCT03965195
- Locations
- 🇺🇸
Insight Therapeutics, LLC, Norfolk, Virginia, United States
Adjuvanted Influenza Vaccination Year 2 Follow-On Survey
- Conditions
- InfluenzaInfluenza-like IllnessInfluenza, Human
- First Posted Date
- 2018-07-26
- Last Posted Date
- 2023-03-16
- Lead Sponsor
- Insight Therapeutics, LLC
- Target Recruit Count
- 598
- Registration Number
- NCT03599739
- Locations
- 🇺🇸
Insight Therapeutics, LLC, Norfolk, Virginia, United States
A Pilot Clinical Trial of TENA Identifi in the Nursing Home Setting
- Conditions
- Urinary Incontinence
- First Posted Date
- 2017-07-06
- Last Posted Date
- 2019-07-26
- Lead Sponsor
- Insight Therapeutics, LLC
- Target Recruit Count
- 49
- Registration Number
- NCT03209570
- Locations
- 🇺🇸
Chesapeake Health & Rehabilitation Center, Chesapeake, Virginia, United States
🇺🇸Norfolk Health & Rehabilitation Center, Norfolk, Virginia, United States
🇺🇸Insight Therapeutics, LLC, Norfolk, Virginia, United States
Immunogenicity of Influenza Vaccine in Long Term Care
- Conditions
- Influenza
- First Posted Date
- 2016-10-14
- Last Posted Date
- 2021-03-09
- Lead Sponsor
- Insight Therapeutics, LLC
- Target Recruit Count
- 200
- Registration Number
- NCT02933723
- Locations
- 🇺🇸
Case Western Reserve University, Cleveland, Ohio, United States
- Prev
- 1
- 2
- Next